Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4789 | LNAI Lunai Bioworks Inc. - Common Stock | 2.72 USD | -3.55% | -11.69% | +15.74% | +75.48% | 12.33 M USD | ||
| 4792 | MBRX Moleculin Biotech, Inc. - Common Stock | 2.28 USD | -1.72% | -16.18% | -6.56% | -27.62% | 12.17 M USD | ||
| 4794 | XCUR Exicure, Inc. - Common Stock | 1.81 USD | -6.70% | -12.56% | -38.01% | -73.38% | 11.54 M USD | ||
| 4797 | PHIO Phio Pharmaceuticals Corp. - Common Stock | 1.01 USD | 0.00% | 0.00% | -7.34% | -15.13% | 11.73 M USD | ||
| 4807 | KPRX Kiora Pharmaceuticals, Inc. - Common Stock | 2.56 USD | +0.39% | -4.83% | 0.00% | +21.90% | 11.35 M USD | ||
| 4808 | GDTC CytoMed Therapeutics Limited - Ordinary Shares | 0.94 USD | 0.00% | -7.84% | -12.15% | -58.59% | 11.12 M USD | ||
| 4813 | BCDA BioCardia, Inc. - Common Stock | 0.93 USD | -8.82% | -24.39% | +10.71% | -19.83% | 10.58 M USD | ||
| 4816 | CVM Cel-Sci Corporation Common Stock | 1.27 USD | -0.78% | +20.95% | -5.93% | -75.34% | 10.79 M USD | ||
| 4820 | TRAW Traws Pharma, Inc. - Common Stock | 0.69 USD | -1.43% | -17.86% | -50.00% | -55.19% | 10.45 M USD | ||
| 4822 | TOVX Theriva Biologics, Inc. Common Stock | 0.23 USD | -4.17% | -8.00% | -11.54% | -8.00% | 10.56 M USD | ||
| 4836 | VTGN Vistagen Therapeutics, Inc. - Common Stock | 0.23 USD | -4.17% | -8.00% | -57.41% | -55.77% | 9.44 M USD | ||
| 4850 | APRE Aprea Therapeutics, Inc. - Common Stock | 0.76 USD | -1.30% | -5.00% | -1.30% | -58.92% | 9.41 M USD | ||
| 4853 | QNRX Quoin Pharmaceuticals Ltd - American Depositary Shares | 4.63 USD | -3.54% | -3.14% | +2.89% | -50.32% | 9.30 M USD | ||
| 4857 | CRIS Curis, Inc. - Common Stock | 4.74 USD | -10.40% | +1002.33% | +887.50% | +156.22% | 9.24 M USD | ||
| 4861 | CVKD Cadrenal Therapeutics, Inc. - Common Stock | 3.07 USD | -2.85% | +0.99% | -28.60% | -44.38% | 8.81 M USD | ||
| 4866 | BRTX BioRestorative Therapies, Inc. - Common Stock | 0.35 USD | -5.41% | -12.50% | -2.78% | -79.77% | 8.92 M USD | ||
| 4879 | IMNN Imunon, Inc. - Common Stock | 2.03 USD | +4.10% | +14.69% | -0.98% | -37.54% | 8.53 M USD | ||
| 4881 | ELOX Eloxx Pharmaceuticals, Inc. | 11.60 USD | +5.94% | -5.77% | +16.00% | +16.00% | 7.99 M USD | ||
| 4888 | MTVA MetaVia Inc. - Common Stock | 1.55 USD | -1.90% | +6.90% | -14.84% | +138.46% | 8.00 M USD | ||
| 4898 | RNAZ TransCode Therapeutics, Inc. - Common Stock | 8.00 USD | -5.21% | +14.94% | +55.64% | -15.88% | 7.60 M USD |
Nouvelles Biotechnology Stocks
Seres Therapeutics publie des données préliminaires sur les complications de la thérapie contre le cancer | Benzinga France
TD Cowen réitère son avis d’achat sur Prime Medicine après une victoire en arbitrage
BofA maintient sa recommandation sur Beam Therapeutics après la décision arbitrale
Pourquoi l’action Beam Therapeutics chute-t-elle aujourd’hui ?
Pourquoi l’action Prime Medicine s’envole-t-elle aujourd’hui ?
L’action Incyte atteint un plus haut de 52 semaines à 118,77 $
L’action Prime Medicine bondit après une victoire en arbitrage contre Beam
Gainers Biotechnology Stocks
TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.36 | +40.65% |
ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0249 | +24.50% |
ELTX Elicio Therapeutics, Inc. - Common Stock | 3.38 | +20.71% |
APLMW Apollomics Inc. - Warrant | 0.0143 | +19.17% |
CBUS Cibus, Inc. - Class A Common Stock | 1.76 | +17.33% |
TTRX Turn Therapeutics Inc. - Common Stock | 11.37 | +17.10% |
PRME Prime Medicine, Inc. - Common Stock | 4.57 | +14.54% |
SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.41 | +13.25% |
Losers Biotechnology Stocks
CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 2.05 | -25.99% |
BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.84 | -19.23% |
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0140 | -16.67% |
JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
MCRB Seres Therapeutics, Inc. - Common Stock | 7.16 | -12.04% |
TVGNW Tevogen Bio Holdings Inc. - Warrant | 0.0501 | -11.64% |
ONCO Onconetix, Inc. - Common Stock | 0.95 | -11.21% |